Home | Back to newsletter main page

Bookmark and Share
Case Comprehensive Cancer Center Newsletter

September 12, 2011

gersonMESSAGE FROM THE DIRECTOR

Stan Gerson, MD
Director, Case CCC

Cancer Center Seminar Series: Issues in the Use of Omics-Based Predictors in Clinical Trials –Notes from an NCI Workshop

Dr. Mark Schluchter, our Associate Director for Biostatistics, has been developing approaches and models for biomarker based clinical investigation. He attended the NCI workshop on this topic this summer, and will report on the consensus issues and recommendations that came from the conference. As a Cancer Center, we identified Biomarker informed clinical trials as our approach to personalized medicine in cancer investigation, with a goal of identifying appropriate treatments for specific patients. Mark will review the complexity of these issues, lessons learned and advise us how to do this better.

Please participate in this week's Cancer Center Seminar, Friday, September 16 at 12 pm in BRB 105.

NCI Provocative Questions: New RFAs

NCI recently released two RFAs that follow on the effort of Harold Varmus to engage us all in novel thinking about persistent questions in cancer. Many of you have an exciting and provocative response to the 24 major questions that made the cut. Topics include obesity, aging, detection, pathways, etc. Please see the full list in the RFAs: RFA-CA-11-011.html (R01) and RFA-CA-11-012.html (R21).

I would think that 40 applications from the Case Comprehensive Cancer Center would be competitive for the 20 4-year awards.

Good luck!

International Conference of the Society of Integrative Oncology (SIO)

Please participate in the Society of Integrative Oncology meeting November 10-12 in Cleveland.

We have worked hard to bring the Society of Integrative Oncology to Cleveland and their message is quite focused: providing complementary and fully integrated supportive oncology to practitioners and patients. Where successful, the approach really adds value to patients physicians and hospitals. The conference will provide new information on practical experience with supportive oncology measures, traditional medicine, balancing supplements with cancer treatment and cancer care, and methods to boost the immune response to cancer. I think there is a considerable amount to be learned by physicians, support staff, nurses and support specialists.

Please make an effort to register and attend.


CASE CCC IN THE NEWS

'Unrealistic Optimism' Poses Ethical Challenges, May Affect Informed Consent Process
ASCO Post - Sep 1, 2011
I think that these findings highlight the need to develop better ways to affect the quality of informed consent," said Neal J. Meropol, MD, the Lester E. Coleman, Jr. Professor of Cancer Research and Therapeutics and Chief, Division of Hematology and Oncology...


ANNOUNCEMENTS

Ohio Third Frontier Commission Awards Imaging Research

Projects led by Drs. Raymond Muzic and David Wilson and were awarded funding by the Ohio Third Frontier Commission:

Positron Mammographic Imaging: Raymond Muzic, PhD (project leader), Donna Plecha, MD, James O'Donnell, MD, Peter Faulhaber; Piotr Maniawski

Cardiac Perfusion with Computed Tomography (CT): David Wilson, PhD (project leader); Hiram Grando Bezerra, MD; Robert (Chip) Gilkeson; Scott Pohlman.

These grants fund two significant imaging research projects that are part of the Philips Healthcare Global Advanced Imaging Innovation Center, a collaboration among CWRU, UH, and Philips Healthcare.

Case CCC Strategic Plan

All members should have recently received a draft of the Case CCC Strategic Plan for 2012-2018. This plan represents the efforts and discussion of the entire membership, Program Leaders, Executive Committee, and institutional leaders. It will be the basis for our renewal application and for institutional commitments for the coming six years.

Thoughts on gaps, and critical perspectives and needs are greatly appreciated. You may send any comments directly to Dr. Stan Gerson at slg5@case.edu. All feedback will be discussed by the Executive Committee.

If you would like a copy of the Strategic Plan, please email Gillian Todd at gillian.irwin@case.edu.

Mandatory Research Staff Continuing Education Sessions

Research Staff Continuing Education Sessions
The Case CCC will be hosting continuing education sessions for research staff on Thursday, September 22 from 8 am - 12 pm or Friday, September 23 from 1 pm - 5 pm in Taussig Cancer Institute R3-002/003. Parking validation will be provided. Staff need to attend only one continuing education session.

These continuing education sessions are mandatory for all SCC and TCI research staff and is open to staff from other departments and institutes conducting clinical trials in oncology. Topics will cover an overview of the Case Comprehensive Cancer Center, updates and Standard Operating Procedures. Break-out sessions will cover the joint site initiation visit during from several perspectives such as regulatory, nursing, data management and quality assurance.

Please direct any questions to Melissa Kadar, Director of UH/SCC Clinical Trials at melissa.kadar@UHhospitals.org or 216-286-6639.


FUNDING OPPORTUNITIES

CTSC Nutrition Obesity Research Pilot Funding

New Investigators at CWRU are invited to submit applications for pilot projects for potential inclusion in the Nutrition Obesity Research Center Application. Successful proposals will be included in the NIDDK NORC Application and will be considered for funding beginning November 2011. For the purpose of this RFP, new investigators are those without current or prior NIH research project support (R01, P01, R24) as a PD/PI. Preference will be given to translational research proposals directed at important questions of Nutrition and Obesity.

Deadline: September 30

Peer Reviewed Cancer Research Program Discovery Award

Applications for the Peer Reviewed Cancer Research Program (PRCRP) are being solicited by the Assistant Secretary of Defense for Health Affairs, Defense Health Program for the Discovery Award. The purpose of this award is to support innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods. Studies supported by this award are expected to develop robust preliminary data that will lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.

Pre-Application Deadline: October 13
Application Deadline: October 27

Oncology Nursing Society Excellence in Oncology Nursing Health Policy and Advocacy Award

The Oncology Nursing Society is currently accepting applications for the Oncology Nursing Health Policy and Advocacy Award. The purpose of this award is to recognize and support achievements and involvement in oncology nursing health policy and advocacy.

Nomination Deadline: October 31

Robert Wood Johnson Foundation Health Policy Fellows

The Robert Wood Johnson Foundation Health Policy Fellows program provides the nation's most comprehensive fellowship experience at the nexus of health science, policy and politics in Washington, D.C. It is an outstanding opportunity for exceptional midcareer health professionals and behavioral and social scientists with an interest in health and health care policy. Fellows participate in the policy process at the federal level and use that leadership experience to improve health, health care, and health policy.

Deadline: November 9

NCI Provocative Questions Project

NCI's Provocative Questions Project is seeking applications from researchers eager to influence the state of cancer research by tackling potentially game-changing scientific questions that could drive progress against cancer. The grants will support research projects that use sound and innovative research strategies to solve specific problems and paradoxes in cancer research.

A total of 24 provocative questions posed during the nationwide Provocative Questions workshops and from website submissions have been selected for inclusion in the RFAs, "Research Answers to NCI's Provocative Questions": RFA-CA-11-011.html (R01) and RFA-CA-11-012.html (R21).

Deadline: November 14


NCI CANCER BULLETIN

September 6, 2011

News
Featured Article: FDA Approves New Drugs to Treat Skin, Blood, and Lung Cancers

Negative Colonoscopy Associated with Low Colorectal Cancer Risk

Smokers at Greater Risk of Bladder Cancer than Previously Estimated

Hereditary Mutations in BAP1 Gene Raise Risk of Mesothelioma

Use of Radioactive Iodine to Treat Thyroid Cancer on the Rise

Colorectal Cancer Genomes Sequenced

Commentary
Inside NCI: A Conversation with Dr. Norm Coleman about Radiation Research

In Depth
Clinical Trial Shows Potential Benefit of HPV Vaccine for Anal Cancer

Targeting the Accomplices: Homing in on Immune Cells that Aid Tumors

The Art of Medicine: Using Narrative and the Humanities in Medical Training

Featured Clinical Trial: Sequencing Treatment with a PARP Inhibitor and Chemotherapy

Updates
NIH Update: NIH Seeks Ideas for Common Fund

Notes

EVENTS

calendar

**All events are open to anyone interested in attending

September 12

Pathology Research Seminar Series
Thomas Egelhoff, PhD
Professor, Cell Biology
CWRU/ Cleveland Clinic
Topic: Myosin II Motor Proteins: Cytoskeletal Roles in Cancer Cell Migration and Skin Development
12 pm WRB 1-413


September 13

Cancer Biology Seminar
Janet Houghton, PhD
Professor and Chair, Cancer Biology
CWRU/Cleveland Clinic
Topic: The Department of Cancer Biology: 2006-2011 and Beyond
11 am NC1-202 Cleveland Clinic

Leaders in AIDS Research Seminar
Christopher Aiken, PhD
Professor, Pathology, Microbiology and Immunology
Vanderbilt University
Topic: The HIV-1 Capsid: Target of Host Restriction Factors and Small Molecule Inhibitors
1 pm SOM W203


September 14

Hematology and Oncology Division Research Conference
Cheng Chee, MD
Assistant Professor, Medicine- Hem/Onc
CWRU/UH
Topic: Overview of Hepatobiliary Cancers
8 am Lerner B-151

NCRM Lunch and Learn
Kirsten Crapnell, PhD
Leader, Discovery Platform Technologies, Cell and Tissue Technologies
BD Biosciences Pharmingen
Topic: Rapid Expansion of human Mesenchymal Stem Cells using BD Mosaic SF MSC Medium
AND
Michael Hulsey
Technical Application Specialist
BD Biosciences Pharmingen
Topic: Isolation and Analysis of Hematopoietic, Pluripotent, and Neuronal Stem Cells
11 am WRB 2-136

NCRM Monthly Seminar
Saba Valadkhan, MD, PhD
Assistant Professor, RNA Molecular Biology
CWRU
Topic: Reprogramming of Mesodermal Cells into Neurons by a Long Non-coding RNA
4:30 pm WRB 1-413


September 15

TGFβ Focus Group Meeting
1 pm WRB 2-136


September 16

Hematology/Oncology Fellows Conference
Paula Silverman, MD
Associate Professor, Medicine-Hem/Onc
CWRU/UH
Topic: Introduction to Advanced Stage/Metastatic Breast Cancer
8 am Wearn 137

Taussig Cancer Institute Grand Rounds
Richard Cote, MD
Professor and Chair, Pathology
University of Miami
Topic: Novel Methods for Capture and Analysis of Circulating Tumor Cells
8 am R3/002-003 Cleveland Clinic

Cancer Center Seminar Series
Mark Schluchter, PhD
Professor, Epidemiology and Biostatistics
Associate Director for Biostatistics, Case Comprehensive Cancer Center
Case Western Reserve University
Topic: Issues in the Use of Omics-Based Predictors in Clinical Trials –Notes from an NCI Workshop
12 pm BRB 105

Cancer Center Research in Progress
Amar Desai
Graduate Student, Gerson Lab, Medicine- Hem/Onc
CWRU/UH
Topic: Exonuclease 1 and the DNA Damage Checkpoint
4 pm WRB 3-136

 

 

Case CCC Calendar

LRI Calendar


UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS

Graft Versus Host Disease Conference
November 4
Renaissance Cleveland Hotel, 24 Public Square, Cleveland
Brochure

ADDITIONAL UPCOMING SEMINARS & EVENTS

First Ascoli Piceno Conference on Gene Vaccination in Cancer
September 15-17
Ascoli Piceno, Italy
Details

8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions
November 10-12
InterContinental Hotel Cleveland
Details


PREVIOUSLY ANNOUNCED FUNDING OPPORTUNITIES

Lustgarten Foundation Innovator Awards Program- Basic Research
Concept Deadline: September 12
Full Proposal Deadline: October 31

Pezcoller Foundation-AACR International Award for Cancer Research
Deadline: September 12

Lustgarten Foundation Fall 2011: Basic Research Innovator Awards
Concept Proposal Deadline: September 14
Full Application Deadline: October 31

Leukemia & Lymphoma Society (LLS) Scholar
Letter of Intent Deadline: September 15
Application Deadline: October 1

Leukemia & Lymphoma Society (LLS) Scholar in Clinical Research
Letter of Intent Deadline: September 15
Application Deadline: October 1

Leukemia & Lymphoma Society (LLS) Special Fellow
Letter of Intent Deadline: September 15
Application Deadline: October 1

Leukemia & Lymphoma Society (LLS) Special Fellow in Clinical Research (SFCR)
Letter of Intent Deadline: September 15
Application Deadline: October 1

Leukemia & Lymphoma Society (LLS) Fellow
Letter of Intent Deadline: September 15
Application Deadline: October 1

Hope Funds for Cancer Research Postdoctoral Fellowship
Proposal Deadline: September 16

DOD Defense University Research Instrumentation Program (DURIP)
Deadline: September 20

DOD BCRP Clinical Translational Research (CTR) Award
Pre-Application Deadline: September 20
Application Deadline: December 22

DOD BCRP Impact Award
Pre-Application Deadline: September 20
Application Deadline: December 22

AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention
Deadline: September 26

AACR Award for Lifetime Achievement in Cancer Research
Deadline: September 26

AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
Deadline: September 26

AACR Princess Takamatsu Memorial Lectureship
Deadline: September 26

Robert Wood Johnson Foundation Health & Society Scholars program
Deadline: September 30

Szent-Györgyi Prize for Progress in Cancer Research
Deadline: September 30

Burroughs Wellcome Fund Medical Scientist Career Awards
Deadline: October 1

Cancer Research Institute Irvington Institute Fellowship Program
Deadline: October 1

AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship
Deadline: October 11

AACR G.H.A. Clowes Memorial Award
Deadline: October 11

AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship
Nomination Deadline: October 11

AACR Award for Outstanding Achievement in Cancer Research
Deadline: October 11

Robert Wood Johnson Foundation Scholars in Health Policy Research program
Deadline: October 12

AACR Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research
Deadline: October 11

AACR Richard and Hinda Rosenthal Memorial Award
Deadline: October 11

DeGregorio Family Foundation for Gastric and Esophageal Cancer Research and Education
Deadline: November 1

Leukemia & Lymphoma Society Specialized Center of Research Program
Deadline: November 1

Friends of Jose Carreras International Leukemia Foundation (FJCILF) E.D. Thomas Postdoctoral Fellowship
Deadline: November 2

HHMI Medical Research Fellows Program
Deadline: January 11, 2012

Translational Technology Concept Studies of Circulating Tumor and Endothelial Cells (CTC/CEC)
Deadline: Open

AACR Scholar-in-Training Awards - Other Conferences and Meetings
Deadline: Open

Case CCC Protocol Specific Research Support (PSRS)
Deadline: Open

International Union Against Cancer (UICC) International Cancer Technology Transfer Fellowships
Application Deadline: Open

International Waldenstrom's Macroglobulinemia Foundation (IWMF) Research Grant Program
Application Deadline: Open

James S. McDonnell Foundation Collaborative Activity Awards
Application Deadline: Open

NCI Short-Term Scientist Exchange Program
Application Deadline: Open


NIH BULLETIN – Notices and Funding Opportunities

Lab to Marketplace: Tools for Biomedical and Behavioral Research (SBIR [R43/R44]) (PA-11-335)

Produced by:
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
216-844-8317 phone
216-844-7832 fax
gillian.irwin@case.edu

HELP US HELP YOU!

If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!

Send items to gillian.irwin@case.edu.